Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Vo

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation SystemSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Transplantation Direct|October 8, 2025
Tocilizumab Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney TransplantationEdmund Huang, Michie Adjei, Alice Peng, et al.
Transplantation|August 1, 2022
An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft FunctionEdmund Huang, Mark Haas, Matt Gillespie, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2016
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximabJoseph Kahwaji, Stanley C Jordan, Reiad Najjar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 7, 2019
Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipientsEdmund Huang, Supreet Sethi, Alice Peng, et al.
Transplantation|September 25, 2008
Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapyNancy L Reinsmoen, Chih-Hung Lai, Ashley Vo, et al.
Transplantation|April 3, 2020
Interleukin-6: An Important Mediator of Allograft InjuryStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplantation|November 15, 2016
Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant PatientsShili Ge, Artur Karasyov, Aditi Sinha, et al.
Transplantation|August 7, 2019
Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated RejectionBong-Ha Shin, Matthew J Everly, Hao Zhang, et al.
Transplantation|May 13, 2011
Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapyChih-Hung Lai, Kai Cao, Geraldine Ong, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation SystemSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Transplantation Direct|October 8, 2025
Tocilizumab Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney TransplantationEdmund Huang, Michie Adjei, Alice Peng, et al.
Transplantation|August 1, 2022
An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft FunctionEdmund Huang, Mark Haas, Matt Gillespie, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2016
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximabJoseph Kahwaji, Stanley C Jordan, Reiad Najjar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 7, 2019
Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipientsEdmund Huang, Supreet Sethi, Alice Peng, et al.
Transplantation|September 25, 2008
Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapyNancy L Reinsmoen, Chih-Hung Lai, Ashley Vo, et al.
Transplantation|April 3, 2020
Interleukin-6: An Important Mediator of Allograft InjuryStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplantation|November 15, 2016
Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant PatientsShili Ge, Artur Karasyov, Aditi Sinha, et al.
Transplantation|August 7, 2019
Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated RejectionBong-Ha Shin, Matthew J Everly, Hao Zhang, et al.
Transplantation|May 13, 2011
Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapyChih-Hung Lai, Kai Cao, Geraldine Ong, et al.
Pageof 7